THE PROBLEMS ASSOCIATED WITH SWITCHING BRAND-NAME ANTIEPILEPTIC DRUGS TO GENERICS: A FOCUS ON TOPAMAX: A REVIEW OF LITERATURE AND A CASE REPORT
Despite the rather high efficiency of treatment for epilepsy (overall, 65–70 % of patients can achieve remission or show a considerable decrease in the frequency of seizures), there remains a challenge due to the need to use antiepileptic drugs long and regularly: therapy adherence, compliance, trea...
Saved in:
| Main Authors: | K. Yu. Mukhin, O. A. Pylaeva, M. Yu. Bobylova |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
ABV-press
2016-08-01
|
| Series: | Русский журнал детской неврологии |
| Subjects: | |
| Online Access: | https://rjdn.abvpress.ru/jour/article/view/152 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
THE PROBLEM OF AGGRAVATION OF EPILEPTIC SEIZURES DURING THERAPY WITH ANTIEPILEPTIC DRUGS
by: K. Yu. Mukhin, et al.
Published: (2015-04-01) -
Drug interchangeability: Clinical efficacy and safety
by: S. K. Zyryanov, et al.
Published: (2017-06-01) -
Can Generic Medications Be a Safe and Effective Alternative to Brand-Name Drugs for Cardiovascular Disease Treatment? A Systematic Review and Meta-Analysis
by: Bing Luo, et al.
Published: (2025-03-01) -
Comparative analysis of thrombocytopenia incidence in patients treated with generic vs. brand-name linezolid: a cohort study utilizing hospital electronic medical records
by: Zhizhou Wang, et al.
Published: (2025-06-01) -
WHAT IS THERAPEUTIC EQUIVALENCE OF GENERIC DRUG AND HOW TO PROVE IT
by: N. P. Kutishenko, et al.
Published: (2016-01-01)